Karen L. Smith - 18 Aug 2023 Form 3 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Karen L. Smith
Issuer symbol
AUPH
Transactions as of
18 Aug 2023
Net transactions value
$0
Form type
3
Filing time
21 Aug 2023, 16:16:25 UTC
Previous filing
14 Jun 2023
Next filing
06 Jun 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.